Impello Biosciences has a total of 13 patents globally, out of which 2 have been granted. Of these 13 patents, more than 92% patents are active. United States of America is where Impello Biosciences has filed the maximum number of patents, followed by Canada and New Zealand. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Impello Biosciences.
Impello Biosciences was founded in the year 2017. The Company is a biotechnology company that makes agriculture better for everyone.
Do read about some of the most popular patents of Impello Biosciences which have been covered by us in this article and also you can find Impello Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Impello Biosciences patent portfolio.
How many patents does the founder and the CEO of Impello Biosciences have?
The founder Eric Hagstrom has 0 patent and CEO Michael Key (also founder) has 1 patent.
How many patents does Impello Biosciences have?
Impello Biosciences has a total of 13 patents globally. These patents belong to 4 unique patent families. Out of 13 patents, 12 patents are active.
How Many Patents did Impello Biosciences File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Impello Biosciences Applications Filed | Impello Biosciences Patents Granted |
| 2023 | 4 | 1 |
| 2022 | 1 | – |
| 2021 | 7 | 1 |
| 2018 | 1 | – |
How many Impello Biosciences patents are Alive/Dead?
How Many Patents did Impello Biosciences File in Different Countries?
Countries in which Impello Biosciences Filed Patents
| Country | Patents |
| United States Of America | 4 |
| Canada | 1 |
| New Zealand | 1 |
| South Africa | 1 |
| Europe | 1 |
| Australia | 1 |
| Mexico | 1 |
Where are Research Centres of Impello Biosciences Patents Located?
The Research Centre for all the Impello Biosciences patents is the United States of America.
What Percentage of Impello Biosciences US Patent Applications were Granted?
Impello Biosciences (Excluding its subsidiaries) has filed 3 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Impello Biosciences patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Impello Biosciences?
| Law Firm | Total Applications | Success Rate |
| Cooley Llp | 3 | 100.00% |
List of Impello Biosciences Patents
| Impello Biosciences Patents | Title |
| US11638427B2 | Methods And Compositions For Altering Secondary Metabolites In Plants |
| US11147271B2 | Chemicals Which Alter The Production Of Metabolites In Cultivated Plants |
| US20230200385A1 | Methods And Compositions For Altering Secondary Metabolites In Plants |
| US20220183290A1 | Chemicals Which Alter The Production Of Metabolites In Cultivated Plants |
| EP4188090A2 | Methods And Compositions For Altering Secondary Metabolites In Plants |
| WO2023108162A3 | Methods And Compositions To Prevent Plant Pests And Pathogens |
| WO2023150641A3 | Methods And Compositions For Altering Metabolites In Vitis Spp. And Preventing Pests And Pathogens |
| CA3187303A1 | Methods And Compositions For Altering Secondary Metabolites In Plants |
| AU2021318553A1 | Methods And Compositions For Altering Secondary Metabolites In Plants |
| MX2023001129A | Methods And Compositions To Alter Secondary Metabolites In Plants. |
| ZA202302902A | Methods And Compositions For Altering Secondary Metabolites In Plants |
| NZ797555A | Methods And Compositions For Altering Secondary Metabolites In Plants |
| WO2022026613A3 | Methods And Compositions For Altering Secondary Metabolites In Plants |
What are Impello Biosciences key innovation segments?
What Technologies are Covered by Impello Biosciences?
The chart below distributes patents filed by Impello Biosciences